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ABSTRACT
Background: Based on the fact that site-specific amino acid replacement on peptide antigens stimulated T
cell clones to produce increased amount of IFN-γ, we investigated this structure-function relationship, using
various peptide analogues．
Methods: We used three human Th0 clones (BC20.7,BC33.5 and BC42.1) that express distinct TCRα and
TCRβ chains, but recognize the same TCR ligand ; i.e., the same framework of peptide antigen BCGa p84-100
in the context of DRB1*1405. These T cells were stimulated with various peptide analogues, followed by deter-
mination of proliferative responses and IFN-γ production．
Results: Replacement of Leu at peptide position 2 (P2) by amino acids which are less hydrophobic than the
wild type (Val, Ala) or those with similar structural or neutral charge (Thr, Ser), induced increased IFN-γ produc-
tion from T cells. This phenomenon was associated with structural features of TCR, especially the length of
CDR3 region of TCRα. Amino acid replacement at the other positions did not induce increased IFN-γ produc-
tion．
Conclusions: Amino acid substitution at P2 frequently induces increased IFN-γ production in a clone-specific
manner, which is associated with the structure of CDR3 in TCRVα chains．
KEY WORDS
analogue peptide, complementarity determining region 3, interferon gamma, peptide antigens, T-cell
antigen receptor
INTRODUCTION
Recent studies showed that T cell activation is not an
all-or-none type of event ; rather, qualitative changes
in T cell responses can be induced by amino acid sub-
stitutions by either MHC molecules or antigenic pep-
tides, i.e., TCR ligands. Flexibility in recognition re-
sults in T-cell activation in the absence of a prolifera-
tive response, which is designated by the following
terminology as demonstrated in previous studies by
our group and others : partial agonism,1 TCR antago-
nism , 2 anergy , 3 survival 4 and cytokine-specific up-
regulation.5,6
Amino acid residues on antigenic peptides have
been roughly divided into two groups ; one that is
important for binding to TCR (T cell epitope), and the
other that is important for binding to MHC (MHC an-
chor). However, the crystal structure of the human
class II HLA-DR1 complexed with the influenza pep-
tide reported by Stern et al. 7 demonstrated that all
the amino acid residues of the influenza virus peptide
physically made contact with both HLA and TCR ,
with the exception of only one residue at the amino
terminus which is buried deeply in the groove of
class II, hence, there is no possibility for interaction
with TCR.
Allergology International. 2005;54:117-122
ORIGINAL ARTICLE
1Department of Allergy and Immunology, Saitama Medical School,
Moroyama and 2Dapartment of Bioregulatory Medicine and Rheu-
matology, Graduate School, Tokyo Medical and Dental University,
Tokyo, Japan.
Correspondence: Sho Matsushita, Department of Allergy and Im-
munology, Saitama Medical School, 38 Morohongo , Moroyama ,
Saitama 350−0495, Japan.
Email: shomat@saitama−med.ac.jp
Received 5 May 2004. Accepted for publication 9 April 2004.
2005 Japanese Society of Allergology
Allergology International Vol 54, No1, 2005 www.js-allergol.gr.jp 117
Table 1　A panel of labeled TCRAV-specific oligonucleo-
tide probes
poolsequenceAV gene
ATGCTAAGACCACA/CCAGCCAV4, 20
ATCTTCAGAGGGAGCTGTGAV11
BATCCTTGAGAGTTTTACTAV2
BCCATTCGAGCTGTATTTA AV8a
BGCATTCGAGCTTTATTTA AV8b
BCATTTGCTGGATTTTCGT AV15
BGATCTTAGGAGCATCATT AV17
BTGGGGGCATCAGTGCTGAAV21
CGAGAAGAGGATCCTCAGG AV3
CACTATTCTCCAGCATACT AV5
CCCGTGTCCATTCTTTGGA AV10
CGAGAGGAATACAAGTGGA AV13
CCAATTTTTGTTGGCTATT AV19
CAGCATCTGACGACCTTCT AV24
CTCCTTGAACATTTATTAA AV25
CCCTAGGGATATTGGGGTT AV26
CGAAAAAACTATACCATCT AV27
CCAGGCACCTTGTTGTGGC AV29
CACTCATCACATCAATGTT AV32
DCTTTGGCAGCCCCATTAC AV18
DGAGACCCTCTTGGGCCTG AV23
DACTAACTTTCGAAGCCTA AV28
DGGAGTGTGCATTCATAGT AV30
EGGAGGCACTA/GCAGGACAA AV7
FACAGCTTCACTGTGGCTAAV6
FTGCCAGCCTGTTGAGGGCAV12
FGTGA/GTCTCCACCTGTCTTAV14
GCTCCTGTTGCTCATACCAAV1a
GCTCCTGCTGCTCGTCCCA AV1b
GCTCCTGGAGCTTATCCCA AV1c
GAAGCCCACCCTCATCTCA AV9
GGCCTCTGCACCCATCTCG AV16
GCTGATACTCTTACTGCTT AV22
GCCTCTCTGGACTTTCTAA AV31
Oligomucleotide probes specific to TCRAV family genes. De-
generated probes were used to specify AV4 and AV20, AV7, and 
AV14 families. Three probes for AV1 family, and two probes for 
AV8 family were required to specify al members of each family. 
These probes were grouped into seven pools (pool A to G) de-
pending on sequence similarity.
In our previous studies, single amino acid substitu-
tions on a group I allergen in the Cryptomeria japon-
ica -derived peptide resulted in a significant increase
in IFN-γ production , with no remarkable changes
either in proliferative response or IL-4 production.5 In
this study, by using various analogue peptide species,
we stimulated three human Th0 clones that express
distinct TCRα and TCRβ chains, but recognize the
same TCR ligand , and tried to determine the
structure-function relationship that leads to increased
IFN-γ production from T cells．
METHODS
SYNTHESIS OF PEPTIDES
The wild-type BCGa p 84-100 ( EEYLILSARD-
VLAVVSK) and its analogue were synthesized using
a solid-phase simultaneous multiple peptide synthe-
sizer PSSM-8 (Shimadzu Corp., Kyoto, Japan), and
were purified by C18 reverse-phase HPLC (Milli-
pore)．
T CELL CLONES
BCGa p84-100-specific T cell lines were established
as described.8 Three human CD4+ T cell clones (BC
20.7,BC33.5 and BC42.1) specific to BCGa p84-100+
DRADRB1*1405, yet bearing distinct TCRβ (BV13S3
,BV6S1 and BV5S4, respectively ; )8 established from
PBMC of a BCG-primed healthy individual as de-
scribed elsewhere,4 were used throughout the study.
T cells were fed 50 Uml human rIL-2 and irradiated
autologous PBMC prepulsed with the wild-type
BCGa p84-100 on a weekly basis．
ASSESSMENT OF T-CELL RESPONSES
Antigen-induced proliferation of the T cell clones
were assayed by culturing the T cells (3×104well) in
96-well flat-bottomed culture plates in the presence of
a peptide(s) and irradiated PBMC (1.5×105well), us-
ing RPMI 1640 medium (Gibco, Grand Island, N.Y.)
supplemented with 2 mM L-glutamine, 100 unitsml
of penicillin , 100 μgml of streptomycin , and 10%
heat-inactivated autologous plasma. For the prolifera-
tion assay, cells were cultured for 72 hr in the pres-
ence of 1 μCiwell of[3H]thymidine during the final
16 hrs . Culture supernatants collected immediately
before the addition of[3H]thymidine were used to de-
termine lymphokine concentrations, using hGM-CSF
ELISA kits (R&D systems) and hIFN-γ ELISA kits
(Otsuka,Tokyo,Japan)．
DETERMINATION OF TCRA GENE USAGE BY T
CELL CLONES
To determine TCRVA gene usage of the T cell clones
that were cultured with irradiated autologous PBMC,
RNA were extracted from the cell mixture, and con-
verted to cDNA. TCRA variable region cDNA were
amplified with anchored PCR as described previously
for amplification of TCRA variable region cDNA.9 A
primary PCR was followed by two sequential nested
PCR. TCRAC-specific primers used for primary PCR,
nested PCR, and final PCR were CA4 (5’-CAG AAT
CCT TAC TTT GTG AC), CA3 (5’ -ATC GGT GAA
TAG GCA GAC AG), and biotinylated CA5 (5’- CAC
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Table 2 TCRVA and TCRVB usage of BC clones
TCRVB TCRVABC clone
(BV12S3)CASRQAGTAYE(BJ2S7)(AV25S1)FCAGHNAG(AJ14S3)20.7
(BV6S1A1)CASSPTGTANT(BJ1S1)(AV3S1)FCATERGQ(AJ13S2)33.5
(BV5S1A1)CASRRSTGE(BJ2S2)(AV8S1A1)FCAASLDNY(AJ126)42.1
TCRVA and VB usage are shown, with amino acid sequences in the N(D)N region.
TGG ATT TAG AGT CTC TC), respectively. A panel
of labeled TCRAV-specific oligonucleotide probes
(Table 1) were used to study TCRAV gene usage with
PCR-ELISA.10 First , seven pools of the AV-specific
probes were hybridized with immobilized PCR prod-
ucts in microplates to find out positive wells. Then,
the products were hybridized with individual AV
probes in another set of plates to pin-point the AV
genes predominantly used by the cDNA. To clone the
entire variable region cDNA, cDNA were amplified
with CA4 and reamplified with a nested primer, CA2
(5’-ACG CGT CGA CAC TGG ATT TAG AGT CTC
TC). The products were subcloned into pBluscript II
SK+ (Stratagene, La Jolla), and recombinant clones
with the dominant VA gene were selected with dot
blot DNA hybridization using corresponding VA-
specific oligonucleotides. After sequence determina-
tion of these clones, dominant clones were selected
as cDNA for the T cell clones．
RESULTS
TCRVA AND VB SEQUENCES
TCRVA and VB sequences of three T-cell clones BC
20.7, BC33.5 and BC42.1 are shown in Table 2. The N
(D)N region sequences are shown as one-letter codes
for amino acids, between V and J segments in paren-
theses. As described in our earlier studies, these T-
cell clones recognize BCGa p84-100 (EEYLILSARD-
VLAVVSK ; with first anchor underlined), in the con-
text of HLA-DRB1*1405.4 It is especially important to
note that N(D)N region consists of 8 and 11 residues
at TCRVA and VB of BC20.7 and BC33.5, respec-
tively, whereas that of BC42.1 consists of 9 and 9 resi-
dues, repectively.
STIMULATORY ACTIVITIES OF BCGA P84-100-
DERIVED ANALOG PEPTIDE L87V TO BC20.7
To evaluate the effects of single amino acid substitu-
tions, proliferation and lymphokine production in re-
sponse to analogue peptides were determined and
findings were compared with those seen with the
wild-type peptide. Most of the analogue peptides that
stimulated BC clones showed a pattern of lym-
phokine production similar to that for the wild-type
peptide (not shown). However, IFN-γ production of
BC20.7 was increased in response to several ana-
logue peptides at high concentration (16 μM), espe-
cially peptide L87V in which Leu is replaced by Val at
the 87 th residue of the peptide BCGa p 84-100,
whereas neither T cell proliferation nor production of
other lymphokines, showed any remarkable change ;
i.e., only the production of IFN-γ was affected for rec-
ognition of the analog peptide L87V. As shown in Fig-
ure 1, to determine whether or not the change of
IFN-γ production was due to differences in the HLA-
peptide or TCR-TCR ligand avidity between L87V and
the wild-type peptide, responses of BC20.7 to several
different concentrations of L87V were compared with
those of the wild-type peptide. In the range of concen-
trations from 0.016 μM up to 16 μM, IFN-γ production
in response to L87V constantly exceeded that of the
wild-type peptide. Moreover, the plateau level of L87
V-driven IFN-γ production was significantly higher .
Mean IFN-γ production of BC20.7 for L87V increased
significantly in comparison to the wild-type, whereas
no statistical differences were noted in proliferative
responses between R21K and the wild-type at a range
of 0.16 μM to 16 μM. The IL-4 production of BC20.7
for each analogue peptide was proportional to the
proliferative response to each peptide, at a range of
0.0016 to 16 μM (not shown). In contrast, production
of GM-CSF gradually increased, in a dose-dependent
manner throughout the range of 0.016 to 16 μM.
These data indicate that the plateau responses and
proliferation of IFN-γ are not due to saturation of the
TCR ligand on the APC surface．
STIMULATORY ACTIVITIES OF BCGA P84-100-
DERIVED ANALOGUES TO THREE BC CLONES
All three T-cell clones were stimulated with ana-
logues at 16 μM, with replacements at P1 (=86Y)
through P9 (=94V). Table 3 summarizes the results,
regarding proliferative responses and IFN-γ produc-
tion. P1 (=86Y) replaced by Ala (A) indicates a pep-
tide species EEALILSARDVLAVVSK. Relative IFN-γ
responses are shown, where IFN-γ production was di-
vided by proliferation. P1 replaced by A gave values
of 9610098, indicating that BC20.7,BC33.5 and BC
42.1 exhibited 96%, 100% and 98% responses respec-
tively, as compared with the wild-type. Asterisks indi-
cate peptide species that did not exert full agonistic
activity ; i.e., peptide stimulation even at 16 μM did
not give a plateau response.
Most of analogues that exhibited full agonistic ac-
tivity, stimulated IFN-γ production at levels roughly
similar to the wild-type peptide, i.e., at around 100%.
However, it is important to note that L87T,L87S,L87A,
and L87V significantly(p<0.01) induced increased lev-
els of IFN-γ production of BC20.7 and BC33.5, but not
of BC42.1. Such a clone-specific phenomenon was
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Increased IFN-γ production induced by peptide analogues
Fig. 1 IFN-γ production, GM-CSF production and proliferation of BC20.7 in recognition of either the wild-type peptide or L87V, 
at diferent concentrations. BC20.7 cels were cultured in triplicate with peptides and iradiated autologous PBMC, at the indi-
cated concentrations. After 48-h incubation, supernatant fluids of triplicate cultures were colected. The remaining cels were 
pulsed with [3H]-thymidine, harvested after 16h, and subjected to liquid scintilation counting. Closed circle, wild type peptide; 
open circle, L87V. Results are expressed as the geometric means ± standard eror. IFN-γ production induced by L87V was sig-
nificantly (p<0.01) higher than that induced by the wild-type peptide, at peptide concentrations ranging from 0.016 to 16 μM. On 
the other hand, plateau level of proliferation did not exhibit a significant diference, between 0.16 and 16 μM (p>0.05). GM-CSF 
production did not reach a plateau response even at 16 μM, without any statistical diference between L87V and the wild-type 
peptide, at 16 μM.
10
5
0
0.0160.0016
0.05 0.50.005
0.16
IFN-γ Production GM-CSF  Production
(ng/ml) (ng/ml)(∆cpm×10－4)
16
5
1.6
0
0.0160.0016
0.05 0.50.005
0.16 16
5
1.6 0.0160.0016
0.05 0.50.005
0.16 16
5
1.6
8
6
4
2
Proliferation
Peptide concentration (µM)
3
2
1
0
0 0 0
also observed when P5- and P8-substituted analogues
were tested. Thus, S90E,S90G,S90M,D93Q,D93T and
D93Y exhibited full agonism, in a clone-specific man-
ner．
DISCUSSION
It is not very easy to identify TCR genes used by T
cell clones, since they are usually cultured with irradi-
ated autologous PBMC that includes polyclonal T
cells. Random cloning of TCR cDNA derived from the
cultured cells is minimally helpful in the identifica-
tion, unless a large number of clones are examined.
This problem was circumvented by the use of PCR-
ELISA that was developed for TCRBV use,9 and es-
tablished in the present report for TCRVA usage .
This technique allowed us to quantitate TCRV gene
usage in the cDNA samples, and thus to identify the
TCRV gene used by the T cell clones.
Three T-cell clones used in the present study rec-
ognize the same TCR ligand, as proven in our previ-
ous study. This is based on the fact that these clones
recognize BCGa p 84-100(84EEYLILSARDVLAVVSK
100) in the context of DRB1*1405, and react to trun-
cated peptides in a similar fashion.11 Both BC20.7 and
BC33.5 have 8 and 11 residues at N(D)N region of
TCRVA and VB, respectively, whereas BC42.1 alone
exhibits a different pattern, i.e., 9 residues at N(D)N
regions of TCRVA and VB. When peptide antigen is
presented by class II MHC molecules, the N-terminal
half of antigenic peptide is recognized mainly by
CDR3 of TCRVA , whereas the C-terminal half is
recoginized by CDR3 of TCRVB, which corresponds
to N(D)N regions.12 Interestingly, certain amino acid
replacements on P2 induced increased IFN-γ produc-
tion in BC20.7 and BC33.5 but not in BC42.1 cells,
whereas those on P8 exhibited full agonism in BC
42.1 cells alone. It is thus likely that structural fea-
tures of VACDR3 and VBCDR3 are responsible for
specific responses induced by P2 and P8 analogues,
respectively. Shuffling of N(D)N sequences between
BC 42.1 and BC 20.7, or between BC 42.1 and BC
33.5 is underway to address this point．
Only L87T,L87S,L87A,and L87V induced IFN-γ en-
hancement. These arrangements are either smaller
hydrophobic (A and V), or structurally similar neutral
amino acids (T and S), indicating that close contact
between P2 and TCRVA is taking place. Indeed, such
a phenomenon is also seen in B-cell somatic hyper-
muation.13 Thus, B-cell V region mutation in immuno-
globulin heavy chain genes shows higher affinity
than the germ-line sequence, usually associated with
Gly, Ala, Val, Ser, Thr, or Cys, i.e., small hydrophobic
or small neutral residues. Apparently these mutations
are not associated with static charges, but can affect
either hydrogen bonding, van der Waar’s force, or hy-
drophobic interactions.
In our previous studies using cedar pollen-derived
peptides, T to V replacement on P2 also induced IFN-
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γ enhancement, whereas proliferation remained the
same. Therefore, although not generalized, mutual
replacement on G, A, V, L, S, or T at P2, tends to in-
duce IFN-γ-specific enhancement. Such observations
also have been reported in another study with differ-
ent peptide species.14 In this sense, analogue-induced
clonal anergy is often observed, especially when resi-
due replacement is made on P7 or P8.11 Moreover,
truncation of the C-terminal moiety of antigenic pep-
tides, in general, exhibit TCR antagonism.15 In other
words, if a rule that applies to altered polyclonal novel
responses induced by peptide analogues is estab-
lished, it will lead us to novel therapeutic interven-
tions using peptide analogues. Our observations on
P2 replacement which is associated with increased
IFN-γ production are imperative to furthering our un-
derstanding．
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